$130.90
$-0.27 (-0.21%)
End-of-day quote: 05/01/2024
NasdaqGS:SRPT
Sarepta Therapeutics Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.24B | $933.01M | $701.89M | $540.10M | $380.83M | $301.03M | $154.58M | $5.42M | $1.25M | $9.76M | $14.22M | $37.33M | $46.99M | $29.42M | $17.59M | $21.26M | $10.99M | $0.12M | $4.78M | $0.43M | |
| GM % | Gross Margin % |
|
17.34% | -8.37% | -23.63% | -45.46% | -62.09% | -43.55% | 95.24% | 0.00% | 0.00% | 0.00% | 0.00% | -39.12% | -41.23% | 100.00% | -38.73% | -28.57% | -182.73% | 0.00% | -233.58% | 0.00% | |
| OM | Operating Margin |
|
-21.54% | -56.83% | -64.00% | -104.44% | -137.10% | -113.59% | -92.25% | 0.00% | 0.00% | 0.00% | 0.00% | -78.00% | -74.12% | -71.16% | -88.18% | -82.52% | -286.65% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.64 | $-3.06 | $-3.80 | $-5.83 | $-4.30 | $-2.14 | $-1.51 | $-3.94 | $-4.44 | $-3.32 | $-2.63 | $-5.14 | $-0.12 | $-1.74 | $-1.62 | $-2.04 | $-3.00 | $-3.54 | $-2.22 | $-4.14 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | 0 | |
| Sha. | Shares |
|
93.73m | 87.95m | 87.13m | 79.37m | 75.18m | 71.07m | 64.79m | 54.76m | 45.63m | 41.31m | 37.75m | 31.7m | 22.62m | 18.73m | 18.42m | 11.85m | 10.74m | 8.86m | 8.53m | 6.02m | |
| OCF | Operating Cash Flow |
|
$-500.99M | $-325.35M | $-443.17M | $107.47M | $-456.46M | $-388.66M | $-232.00M | $-245.82M | $-149.47M | $-128.54M | $-64.70M | $-29.69M | $-23.68M | $-15.21M | $-8.80M | $-12.34M | $-24.68M | $-20.61M | $-14.67M | $-23.78M | |
| FCF | Free Cash Flow |
|
$-503.00M | $-356.17M | $-481.66M | $25.26M | $-516.09M | $-449.82M | $-244.00M | $-251.16M | $-152.87M | $-153.98M | $-67.07M | $-29.80M | $-24.86M | $-16.04M | $-9.73M | $-12.71M | $-25.95M | $-21.38M | $-15.74M | $-24.85M | |
| FCFS | Free Cash Flow Per Share |
|
$-5.26 | $-4.07 | $-4.67 | $1.71 | $-7.05 | $-6.84 | $-2.18 | $-5.19 | $-3.65 | $-3.88 | $-2.02 | $-1.31 | $-1.20 | $-0.93 | $-0.70 | $-1.17 | $-2.98 | $-2.51 | $-2.17 | $-4.22 |
